Cargando…
The traditional chinese medicine monomer Ailanthone improves the therapeutic efficacy of anti-PD-L1 in melanoma cells by targeting c-Jun
BACKGROUND: C-Jun, a critical component of AP-1, exerts essential functions in various tumors, including melanoma, and is believed to be a druggable target for cancer therapy. Unfortunately, no effective c-Jun inhibitors are currently approved for clinical use. The advent of immune checkpoint inhibi...
Autores principales: | Yu, Pian, Wei, Hui, Li, Kaixuan, Zhu, Shiguo, Li, Jie, Chen, Chao, Zhang, Detian, Li, Yayun, Zhu, Lei, Yi, Xiaoqing, Liu, Nian, Liu, Panpan, Zhao, Shuang, Chen, Xiang, Peng, Cong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9753288/ https://www.ncbi.nlm.nih.gov/pubmed/36522774 http://dx.doi.org/10.1186/s13046-022-02559-z |
Ejemplares similares
-
Ailanthone inhibits non-small cell lung cancer cell growth through repressing DNA replication via downregulating RPA1
por: Ni, Zhongya, et al.
Publicado: (2017) -
Ailanthone Induces Cell Cycle Arrest and Apoptosis in Melanoma B16 and A375 Cells
por: Liu, Wenjing, et al.
Publicado: (2019) -
CD147 Facilitates the Pathogenesis of Psoriasis through Glycolysis and H3K9me3 Modification in Keratinocytes
por: Chen, Chao, et al.
Publicado: (2023) -
Ailanthone: A novel potential drug for treating human cancer
por: Ding, Haixiang, et al.
Publicado: (2020) -
Ailanthone targets p23 to overcome MDV3100 resistance in castration-resistant prostate cancer
por: He, Yundong, et al.
Publicado: (2016)